<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-06T11:17:02+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-UNOPS-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Myanmar (01-Jan-2011-31-Dec-2012)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, United Nations Office for Project Services</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-UNOPSP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2011-01-01" />
    <activity-date type="2" iso-date="2011-01-01" />
    <activity-date type="3" iso-date="2012-12-31" />
    <activity-date type="4" iso-date="2012-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="f0a558f3-bf26-4339-ae23-da2149bf4ff4">
      <transaction-type code="3" />
      <transaction-date iso-date="2010-12-13" />
      <value currency="USD" value-date="2010-12-13">6618574.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0be7bd8b-1ce8-446e-a77c-fc1b69eb25cf">
      <transaction-type code="3" />
      <transaction-date iso-date="2010-12-20" />
      <value currency="USD" value-date="2010-12-20">567466.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="67b5c16e-3102-4c35-8129-cf41a6d8cfbd">
      <transaction-type code="2" />
      <transaction-date iso-date="2011-01-01" />
      <value currency="USD" value-date="2011-01-01">24621616.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c989c70d-970e-4e54-a00b-84ef6c84a940">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-03-16" />
      <value currency="USD" value-date="2012-03-16">8380518.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f7b418bd-d167-4c3d-ac29-60a79460a69f">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-09-14" />
      <value currency="USD" value-date="2012-09-14">1030974.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ff51459c-870b-408f-9c44-97dfac29c07f">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-12-17" />
      <value currency="USD" value-date="2012-12-17">8024084.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-UNOPS-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>TB control to reduce morbidity, mortality and transmission of TB in Myanmar - Myanmar (01-Jan-2013-31-Dec-2016)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar faces a major public health problem in Tuberculosis (TB).  The country is listed among the 22 high TB burden countries, among the 41 high TB and HIV burden countries and among the 27 high multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB burden countries. In 2007, an estimated 124,416 TB cases were notified in all forms, corresponding to a case notification rate of 265 cases per 100,000 population.  The program is implemented through a Dual Financing Track scheme and focuses on TB and high risk patients.  The proposal for this grant builds on the National TB Strategic Plan 2011 to 2015, and coordinated with both the National HIV/AIDS and Malaria proposals. The program aims to reduce the burden of TB by 2015 in line with the Millennium Development Goals (MDG) and Stop TB components of the new Stop TB Strategy.  The activities under current grant focus on engaging health providers through Public-Private Mix DOTS (Directly Observed Treatment, Short-Course), Public-Public Mix DOTS and introducing the International Standards of TB Care (ISTC).</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the burden of TB by 2015 in line with the MDGs and STOP TB Partnership targets. Objectives: Addressing TB/HIV, MDR-TB and other challenges such as TB care for high risk groups in border areas and infection control; Advocacy, Communication, Social Mobilization (ASCM) and community based DOTS in hard-to-reach areas by partner agencies; Engaging all health care providers through Public-Private Mix DOTS, Public-Public Mix DOTS and introducing the International Standards of TB Care (ISTC) in other sectors; Pursuing high quality DOTS: Enhancing the quality and expanding services to all TB patients, to sustain and further imporve case detection and treatment success rates.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-UNOPSP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2013-01-01" />
    <activity-date type="2" iso-date="2013-01-01" />
    <activity-date type="3" iso-date="2016-12-31" />
    <activity-date type="4" iso-date="2016-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="a1746a65-f0a8-4460-8231-8e5f9f15d137">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-08-27" />
      <value currency="USD" value-date="2013-08-27">10584529.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5375371e-df9f-47a6-b334-3f11be9e892c">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-12-16" />
      <value currency="USD" value-date="2013-12-16">2961301.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e5606c2c-7b6f-4000-9731-f255d0ab5219">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-01-16" />
      <value currency="USD" value-date="2014-01-16">16671223.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b4ad713c-7845-4c86-8910-706dbfe10c58">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-06-03" />
      <value currency="USD" value-date="2014-06-03">24365400.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="84a99d2e-e83d-4df4-94a6-f2693eb737c2">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-06-03" />
      <value currency="USD" value-date="2014-06-03">-3125393.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5196e52f-54f9-4c9e-bf1e-777e8e67d0d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-06-04" />
      <value currency="USD" value-date="2014-06-04">7688915.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf42fcb7-e61e-4037-ac7b-1bb31ae350db">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-11-06" />
      <value currency="USD" value-date="2014-11-06">4837964.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9ef5050e-e458-4494-b62b-4d1696248ff4">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-12-16" />
      <value currency="USD" value-date="2014-12-16">11838521.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b353e06a-a90a-4012-abe1-510ba155e471">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-08-26" />
      <value currency="USD" value-date="2015-08-26">20108037.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec1a6920-a257-47ac-bf1f-eeb380fabf8e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-28" />
      <value currency="USD" value-date="2015-08-28">2535834.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3c1d016-f56c-49ed-9e8a-826ea9250277">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-04-01" />
      <value currency="USD" value-date="2016-04-01">24188641.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33bb277b-ed00-428c-85ed-d7b0aaa04cea">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-04-01" />
      <value currency="USD" value-date="2016-04-01">-17572203.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="55822120-5e17-44dd-a3f8-0e0c6669c6d4">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-04-04" />
      <value currency="USD" value-date="2016-04-04">11356289.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9e65ce8b-659c-46e6-bf49-80a09722777c">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-08-30" />
      <value currency="USD" value-date="2016-08-30">-12832352.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a610826-9867-4c4b-beef-22fdbd51f362">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-08-30" />
      <value currency="USD" value-date="2016-08-30">22873497.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5949bb74-d30c-4483-8f5d-5b0d577590b8">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-01" />
      <value currency="USD" value-date="2016-09-01">19146497.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="320dfe31-ccd3-43f3-b236-8d260505d4c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-11-30" />
      <value currency="USD" value-date="2016-11-30">-3727000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR TB-other 1: Number of bacteriologically confirmed, drug resistant TB cases (RR-TB and/or MDR-TB) detected</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>MDR TB-other 1: Number of bacteriologically confirmed, drug resistant TB cases (RR-TB and/or MDR-TB) detected</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Current grant. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 442.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 192.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 400.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 881.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 738.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1747.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2276.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1359.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3808.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3213; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Current grant. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 442.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 244.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 508.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 667.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 587.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1747.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1537.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 979.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3808.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1121.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2537; Percentage: 79%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 147984.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 73783.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 153714.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 142170.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 76788.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 66593.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 159974.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 141944.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 81770.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 68623.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 170354.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 82111.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 171065.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 137404; Percentage: 80%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="47467" />
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target value="23537" />
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target value="49034" />
          <actual value="44737" />
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="24376" />
          <actual value="25620" />
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="50782" />
          <actual value="50119" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="25796" />
          <actual value="23989" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="53741" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="25635" />
          <actual value="24986" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="53406" />
          <actual value="49780" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="85.6">
          <comment>
            <narrative>Numerator: 36291; Denominator: 42381.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target value="84.7">
            <comment>
              <narrative>Numerator: 19298; Denominator: 22784.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target value="84.7">
            <comment>
              <narrative>Numerator: 40205; Denominator: 47467.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 35046; Denominator: 41054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="84.7">
            <comment>
              <narrative>Numerator: 19935; Denominator: 23537.</narrative>
            </comment>
          </target>
          <actual value="84.3">
            <comment>
              <narrative>Numerator: 9389; Denominator: 11139.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="84.7">
            <comment>
              <narrative>Numerator: 41531; Denominator: 49034.</narrative>
            </comment>
          </target>
          <actual value="85.8">
            <comment>
              <narrative>Numerator: 35893; Denominator: 41853.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="84.8">
            <comment>
              <narrative>Numerator: 20670; Denominator: 24376.</narrative>
            </comment>
          </target>
          <actual value="83.7">
            <comment>
              <narrative>Numerator: 20163; Denominator: 24083.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="84.8">
            <comment>
              <narrative>Numerator: 43063; Denominator: 50782.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 21926; Denominator: 25796.</narrative>
            </comment>
          </target>
          <actual value="84.83">
            <comment>
              <narrative>Numerator: 10462; Denominator: 12333.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 45679; Denominator: 53741.</narrative>
            </comment>
          </target>
          <actual value="84.9">
            <comment>
              <narrative>Numerator: 39641; Denominator: 46697.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="89.4">
          <comment>
            <narrative>Numerator: 371; Denominator: 415.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target value="92.5">
            <comment>
              <narrative>Numerator: 393; Denominator: 425.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target value="92.5">
            <comment>
              <narrative>Numerator: 393; Denominator: 425.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 387; Denominator: 413.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="92.6">
            <comment>
              <narrative>Numerator: 403; Denominator: 435.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 383; Denominator: 406.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="92.6">
            <comment>
              <narrative>Numerator: 403; Denominator: 435.</narrative>
            </comment>
          </target>
          <actual value="91.7">
            <comment>
              <narrative>Numerator: 399; Denominator: 435.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="92.8">
            <comment>
              <narrative>Numerator: 415; Denominator: 447.</narrative>
            </comment>
          </target>
          <actual value="94.2">
            <comment>
              <narrative>Numerator: 421; Denominator: 447.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="92.8">
            <comment>
              <narrative>Numerator: 415; Denominator: 447.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="92.8">
            <comment>
              <narrative>Numerator: 415; Denominator: 447.</narrative>
            </comment>
          </target>
          <actual value="95.98">
            <comment>
              <narrative>Numerator: 430; Denominator: 448.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="92.8">
            <comment>
              <narrative>Numerator: 415; Denominator: 447.</narrative>
            </comment>
          </target>
          <actual value="94.6">
            <comment>
              <narrative>Numerator: 419; Denominator: 443.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Current grant. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="2.1">
          <comment>
            <narrative>Numerator: 3086; Denominator: 147984.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target value="2.2">
            <comment>
              <narrative>Numerator: 1613; Denominator: 73783.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target value="2.2">
            <comment>
              <narrative>Numerator: 3360; Denominator: 153714.</narrative>
            </comment>
          </target>
          <actual value="2.1">
            <comment>
              <narrative>Numerator: 2975; Denominator: 142170.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="2.3">
            <comment>
              <narrative>Numerator: 1766; Denominator: 76788.</narrative>
            </comment>
          </target>
          <actual value="2.3" />
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="2.3">
            <comment>
              <narrative>Numerator: 3680; Denominator: 159974.</narrative>
            </comment>
          </target>
          <actual value="2.2">
            <comment>
              <narrative>Numerator: 3134; Denominator: 141944.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="2.2">
            <comment>
              <narrative>Numerator: 1766; Denominator: 81770.</narrative>
            </comment>
          </target>
          <actual value="2.2">
            <comment>
              <narrative>Numerator: 1766; Denominator: 81770.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="2.2">
            <comment>
              <narrative>Numerator: 3680; Denominator: 170354.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="2.5">
            <comment>
              <narrative>Numerator: 2053; Denominator: 82111.</narrative>
            </comment>
          </target>
          <actual value="2.59">
            <comment>
              <narrative>Numerator: 1680; Denominator: 64799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="2.5">
            <comment>
              <narrative>Numerator: 4277; Denominator: 171065.</narrative>
            </comment>
          </target>
          <actual value="2.6">
            <comment>
              <narrative>Numerator: 3498; Denominator: 137404.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="96.2">
          <comment>
            <narrative>Numerator: 329; Denominator: 342.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2013-01-01" />
          <period-end iso-date="2013-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 343; Denominator: 343.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2013-07-01" />
          <period-end iso-date="2013-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 343; Denominator: 343.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 344; Denominator: 344.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-UNOPS-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Myanmar (01-Jan-2017-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, United Nations Office for Project Services</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035). Objectives: Objective 1: accelerate the decline in the prevalence of drug-sensitive and drug-resistant TB; Objective 2: fully integrate TB prevention and care in Universal Health Coverage; Objective 3: enhance the prevention of TB, particularly for high-risk populations.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-UNOPSP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2017-01-01" />
    <activity-date type="2" iso-date="2017-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="3bc50c5d-f260-4081-a831-f82a3f69c304">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-01-23" />
      <value currency="USD" value-date="2017-01-23">26091945.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7d33c9bf-dd6c-4e20-998c-36e3fc23003c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-24" />
      <value currency="USD" value-date="2017-01-24">14228995.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7a44804f-5184-48d8-a905-e303ea5b8923">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-23" />
      <value currency="USD" value-date="2017-11-23">4229889.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3754328-e2bc-4369-b919-15f5ef628a3e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-18" />
      <value currency="USD" value-date="2018-01-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f2907780-815d-4b57-99d4-d926b0f2dec1">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">-7583061.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="2793" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="1583" />
          <actual value="1670" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="3297" />
          <actual value="3197" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="2207" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="1583" />
          <actual value="1394" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="3297" />
          <actual value="2666" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="1.9">
          <comment>
            <narrative>Numerator: 42; Denominator: 2207.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="3">
            <comment>
              <narrative>Numerator: 48; Denominator: 1600.</narrative>
            </comment>
          </target>
          <actual value="1.8">
            <comment>
              <narrative>Numerator: 23; Denominator: 1316.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="3">
            <comment>
              <narrative>Numerator: 96; Denominator: 3200.</narrative>
            </comment>
          </target>
          <actual value="1.8">
            <comment>
              <narrative>Numerator: 49; Denominator: 2709.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="97.2">
          <comment>
            <narrative>Numerator: 352; Denominator: 362.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="97.5">
            <comment>
              <narrative>Numerator: 353; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="97.5">
            <comment>
              <narrative>Numerator: 353; Denominator: 362.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="97.5">
            <comment>
              <narrative>Numerator: 353; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="98.1">
            <comment>
              <narrative>Numerator: 355; Denominator: 362.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="16884" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="8890" />
          <actual value="9100" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="18521" />
          <actual value="20032" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="23919" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="13705" />
          <actual value="12904" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="28553" />
          <actual value="28256" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31">
          <comment>
            <narrative>Numerator: 140700.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34443; Denominator: 140700; Percentage: 24.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 53155; Denominator: 140700; Percentage: 37.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 87545; Denominator: 140700; Percentage: 62.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 85369; Denominator: 140700; Percentage: 60.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 43817; Denominator: 140700; Percentage: 31.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 11514; Denominator: 140700; Percentage: 8.2%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 74086.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 62555.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 154345.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 130414.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 48294.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 48516.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 81898.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 105742.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 14576.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 10096.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="92.8">
          <comment>
            <narrative>Numerator: 415; Denominator: 447.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="94">
            <comment>
              <narrative>Numerator: 423; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 431; Denominator: 449.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 423; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 403; Denominator: 425.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="100">
          <comment>
            <narrative>Numerator: 344; Denominator: 344.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 355; Denominator: 355.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="85" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 66677; Denominator: 74086.</narrative>
            </comment>
          </target>
          <actual value="87.2">
            <comment>
              <narrative>Numerator: 54985; Denominator: 63049.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 138910; Denominator: 154345.</narrative>
            </comment>
          </target>
          <actual value="87.7">
            <comment>
              <narrative>Numerator: 118689; Denominator: 135397.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="65.3">
          <comment>
            <narrative>Numerator: 5168; Denominator: 7918.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="72.2">
            <comment>
              <narrative>Numerator: 2729; Denominator: 3781.</narrative>
            </comment>
          </target>
          <actual value="54.1">
            <comment>
              <narrative>Numerator: 2707; Denominator: 5001.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="72.2">
            <comment>
              <narrative>Numerator: 2729; Denominator: 3781.</narrative>
            </comment>
          </target>
          <actual value="56">
            <comment>
              <narrative>Numerator: 2855; Denominator: 5095.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="86.6">
          <comment>
            <narrative>Numerator: 54178; Denominator: 62573.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 42532; Denominator: 44771.</narrative>
            </comment>
          </target>
          <actual value="97.3">
            <comment>
              <narrative>Numerator: 50706; Denominator: 52118.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 47140; Denominator: 49621.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 82510; Denominator: 85142.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="11.2">
          <comment>
            <narrative>Numerator: 3361; Denominator: 29930.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3679; Denominator: 7358.</narrative>
            </comment>
          </target>
          <actual value="5.2">
            <comment>
              <narrative>Numerator: 681; Denominator: 13168.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 4082; Denominator: 8164.</narrative>
            </comment>
          </target>
          <actual value="7.4">
            <comment>
              <narrative>Numerator: 1009; Denominator: 13607.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="63.5">
          <comment>
            <narrative>Numerator: 89350; Denominator: 140700.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 66677; Denominator: 74086.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 55543; Denominator: 62550.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 138910; Denominator: 154345.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 115838; Denominator: 130414.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-UNOPS-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis - Myanmar (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, United Nations Office for Project Services</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035). Objectives: To accelerate the decline in the prevalence of drug-sensitive and drug-resistant TB; To fully integrate TB prevention and care in Universal Health Coverage; To enhance the prevention of TB, particularly for high-risk populations.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-UNOPSP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="61.67">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="38.33">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.63">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="20.59">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2e778829-d9f6-4382-b52a-31c55a719622" percentage="0.38">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Other program management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="2c00622f-0877-4553-993e-389582dbbfd1" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="b0b850b8-142b-4100-bd18-2da244fde07f" percentage="3.58">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Public financial management (country or donor harmonized) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="d60e0ad2-2d4a-4755-8a13-8ca7b743b379" percentage="0.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="1.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.39">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="2.84">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="1.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="a1d59f86-a576-4ed5-bc14-b2d9fc2c3967" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National product selection, registration and quality monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="7319638f-aa8e-41bc-b90c-e0eb35b6797c" percentage="0.22">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Other procurement supply chain management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="a917e4f1-a1df-4b72-a335-1d4b3db2d854" percentage="1.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
        </description>
      </budget-item>
      <budget-item code="f9be36a8-948e-4f4f-860d-8e162eeaa510" percentage="3.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="a9a15642-9d30-4ac6-85fe-0d687727c2d2" percentage="1.41">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Retention and scale-up of health workers, including for community health workers</narrative>
        </description>
      </budget-item>
      <budget-item code="41e196cd-8e22-40d0-8d8e-595683020124" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="10.2">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="01da3c87-13e1-4ce3-9c23-a3d4fd565967" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="3.75">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="5e616c4b-3854-4008-8caa-4cb786ae6fe1" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="43569924-d9cb-4e7a-90e7-975fd08c02de" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="8bfd5db3-426b-4dc3-aec1-929f85b850a4" percentage="0.28">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="0.69">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="99d77148-96ff-4224-993e-9bf00ec91e61" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Removing human rights and gender related barriers to MDR-TB</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="19.83">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="9.77">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="1.27">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="7.4">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="1.42">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.23">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="fbc19cfa-87a0-4ea9-b0f8-b510eb8eab13" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Other TB care and prevention intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="1.5">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="3.86">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.18">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="f6635c15-0555-4875-ac3c-f76851341d6a" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="210d51b7-40a1-4b35-b1fe-14cb15713360" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">18079229.74</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">26631942.68</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">32570199.56</value>
    </budget>
    <capital-spend percentage="9.15" />
    <transaction ref="d806742e-12b8-44b5-87b4-4698e6ea5801">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-19" />
      <value currency="USD" value-date="2017-12-19">36982043.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9b3c66cd-1589-4fb5-9705-b458de69aa65">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-21" />
      <value currency="USD" value-date="2017-12-21">5386812.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="671123d2-749c-4070-963a-32cd21c2d0ba">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">50000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b0122a37-e8eb-4468-9444-f54108fd8562">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">3670258.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d6f88664-c404-425a-b403-792d0ee4db77">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-07" />
      <value currency="USD" value-date="2018-08-07">4045192.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e7a00c02-8da1-41c8-bf7a-3d837146bc60">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-05" />
      <value currency="USD" value-date="2018-10-05">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="82ec8191-60f0-414a-8cc8-cab385616569">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-23" />
      <value currency="USD" value-date="2018-10-23">4452161.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="91701f6d-f3a7-46ee-961a-9781f89afcfd">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">5755252.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7c1409c1-8725-47d9-83b1-3bc7a5a6fd47">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-02" />
      <value currency="USD" value-date="2019-04-02">4169807.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ced00f3c-dd0e-4751-8d22-0dc6299bf780">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-29" />
      <value currency="USD" value-date="2019-05-29">50000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ae1f3841-c35c-4f17-90e9-a9768ff8cecd">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-22" />
      <value currency="USD" value-date="2019-07-22">-9502561.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56f7c33a-7f6e-4026-af42-fd06fc3fada7">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-22" />
      <value currency="USD" value-date="2019-07-22">32975668.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f6a39bd7-df42-481e-b2a8-f393a34b5853">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-23" />
      <value currency="USD" value-date="2019-07-23">8551912.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e577dc70-0c85-4322-b795-6ad03ba5bea9">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-01" />
      <value currency="USD" value-date="2019-10-01">6638278.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f31aa8c6-f021-4cca-acfe-f00e97e8520d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-10" />
      <value currency="USD" value-date="2019-10-10">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e7b92030-9661-44d5-b3d9-64d96b69da1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-14" />
      <value currency="USD" value-date="2020-01-14">3565229.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05c89e1e-4235-4d3f-a83e-83145b822c2e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">6001347.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4f6fadc1-84b9-4883-89ee-d81e93b72e50">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f8f70a7-ae41-4725-b7b7-64674c135591">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-06" />
      <value currency="USD" value-date="2020-07-06">-8218902.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07bd1a5e-9c4c-468d-a79c-b7dac09e6f14">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-06" />
      <value currency="USD" value-date="2020-07-06">19355078.42</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="735c327e-b0c1-4c7b-a09b-5a403f608348">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-15" />
      <value currency="USD" value-date="2020-07-15">8415898.42</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6847779-eff1-48f9-8603-07a60032135d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-02" />
      <value currency="USD" value-date="2020-10-02">8966297.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b92cf569-3187-4103-9590-984d3f3d666f">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e93bf50-8ae4-42f3-9c30-4a3927340402">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-26" />
      <value currency="USD" value-date="2022-07-26">-1972883.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a3581e7-d100-48ae-bf5b-788f66d1d714">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">598.55</value>
      <description>
        <narrative>Funds returned to the Global Fund from MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afc13552-9c0f-49bf-907a-26597b5d90f7">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">833.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from MMR-T-UNOPSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7458855e-2c87-44db-ac3e-3d5e75910c93">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-17" />
      <value currency="USD" value-date="2023-07-17">-833.79</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2dc6620d-7d09-4701-856a-97ee94ba525a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-17" />
      <value currency="USD" value-date="2023-07-17">-598.55</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP04-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">18079229.75</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP04, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP04-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">22449751.99</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP04, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP04-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">28062230.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP04, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP04-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">1921079.96</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP04, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="3213" />
        <baseline year="2016" iso-date="2016-12-31" value="3194">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="3194">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="3194">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="3194">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="3194">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1131">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1131">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1131">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1131">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1131">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2082">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2082">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2082">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2082">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2082">
          <dimension name="Gender" value="Male" />
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="2452" />
          <actual value="1773" />
          <actual value="15">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="81">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="1191">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="1758">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="2453" />
          <actual value="1706" />
          <actual value="1693">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="13">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="600">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="1106">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="2226" />
          <actual value="1668" />
          <actual value="1648">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="20">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="568">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="1100">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="2226" />
          <actual value="1537" />
          <actual value="1521">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="16">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="477">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="1060">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="2313" />
          <actual value="1325" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="2313" />
          <actual value="983" />
          <actual value="975">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="8">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="330">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="653">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="2537" />
        <baseline year="2016" iso-date="2016-12-31" value="2531">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2531">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2531">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2531">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2531">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="6">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="6">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="6">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="6">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="877">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="877">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="877">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="877">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="877">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1660">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1660">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1660">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1660">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="1660">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2537">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2537">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2537">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2537">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="1962" />
          <actual value="1276" />
          <actual value="12">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="837">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="1261">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="436">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="1962" />
          <actual value="1430" />
          <actual value="1421">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="9">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="481">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="949">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="108">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="1825" />
          <actual value="1302" />
          <actual value="1281">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="21">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="468">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="834">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="173">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="1826" />
          <actual value="1279" />
          <actual value="1265">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="14">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="422">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="857">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="190">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="1966" />
          <actual value="1290" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="1967" />
          <actual value="1067" />
          <actual value="1058">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="9">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="368">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="699">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="47.44">
          <comment>
            <narrative>Numerator: 66243; Denominator: 139625.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 47587; Denominator: 79312.</narrative>
            </comment>
          </target>
          <actual value="36.1">
            <comment>
              <narrative>Numerator: 23113; Denominator: 64069.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 47587; Denominator: 79312.</narrative>
            </comment>
          </target>
          <actual value="48.1">
            <comment>
              <narrative>Numerator: 33591; Denominator: 69840.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 46733; Denominator: 71898.</narrative>
            </comment>
          </target>
          <actual value="50.4">
            <comment>
              <narrative>Numerator: 32450; Denominator: 64362.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 46733; Denominator: 71899.</narrative>
            </comment>
          </target>
          <actual value="47.7">
            <comment>
              <narrative>Numerator: 32740; Denominator: 68630.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 52361; Denominator: 74802.</narrative>
            </comment>
          </target>
          <actual value="57.7">
            <comment>
              <narrative>Numerator: 32673; Denominator: 56603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 52361; Denominator: 74802.</narrative>
            </comment>
          </target>
          <actual value="59.6">
            <comment>
              <narrative>Numerator: 27396; Denominator: 45953.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="1.9">
          <comment>
            <narrative>Numerator: 42; Denominator: 2207.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="3">
            <comment>
              <narrative>Numerator: 49; Denominator: 1648.</narrative>
            </comment>
          </target>
          <actual value="1.6">
            <comment>
              <narrative>Numerator: 22; Denominator: 1393.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="3">
            <comment>
              <narrative>Numerator: 49; Denominator: 1649.</narrative>
            </comment>
          </target>
          <actual value="1.8">
            <comment>
              <narrative>Numerator: 21; Denominator: 1188.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="1.8">
            <comment>
              <narrative>Numerator: 33; Denominator: 1825.</narrative>
            </comment>
          </target>
          <actual value="2.2">
            <comment>
              <narrative>Numerator: 26; Denominator: 1165.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="1.81">
            <comment>
              <narrative>Numerator: 33; Denominator: 1826.</narrative>
            </comment>
          </target>
          <actual value="2.9">
            <comment>
              <narrative>Numerator: 38; Denominator: 1295.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="1.53">
            <comment>
              <narrative>Numerator: 30; Denominator: 1966.</narrative>
            </comment>
          </target>
          <actual value="2.9">
            <comment>
              <narrative>Numerator: 38; Denominator: 1302.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="1.53">
            <comment>
              <narrative>Numerator: 30; Denominator: 1967.</narrative>
            </comment>
          </target>
          <actual value="2.4">
            <comment>
              <narrative>Numerator: 31; Denominator: 1279.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="97.51">
          <comment>
            <narrative>Numerator: 353; Denominator: 362.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="98.1">
            <comment>
              <narrative>Numerator: 355; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="98.3">
            <comment>
              <narrative>Numerator: 356; Denominator: 362.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="98.1">
            <comment>
              <narrative>Numerator: 355; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="98.1">
            <comment>
              <narrative>Numerator: 355; Denominator: 362.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="98.1">
            <comment>
              <narrative>Numerator: 355; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="98.2">
            <comment>
              <narrative>Numerator: 325; Denominator: 331.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="98.07">
            <comment>
              <narrative>Numerator: 355; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="81.2">
            <comment>
              <narrative>Numerator: 294; Denominator: 362.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 362; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 363; Denominator: 369.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 362; Denominator: 362.</narrative>
            </comment>
          </target>
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 364; Denominator: 370.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="22017" />
        <baseline year="2016" iso-date="2016-12-31" value="2837">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2837">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2837">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2837">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="2837">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19180">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19180">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19180">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19180">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="19180">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="12558" />
          <actual value="11685" />
          <actual value="10401">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="582">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="13605" />
          <actual value="14009" />
          <actual value="1348">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="12661">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="13632" />
          <actual value="11540" />
          <actual value="1477">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="10063">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="14768" />
          <actual value="13131" />
          <actual value="1278">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="11853">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="14577" />
          <actual value="10021" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="16061" />
          <actual value="8500" />
          <actual value="1857">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="6643">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="427" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="308" />
          <actual value="350" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="308" />
          <actual value="656" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="660" />
          <actual value="560" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="660" />
          <actual value="1047" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="660" />
          <actual value="368" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="660" />
          <actual value="261" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="317" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="360" />
          <actual value="216" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="360" />
          <actual value="277" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="420" />
          <actual value="505" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="420" />
          <actual value="713" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="530" />
          <actual value="1048" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="530" />
          <actual value="1074" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="19769" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="7459" />
          <actual value="4152" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="7459" />
          <actual value="6611" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="12976" />
          <actual value="10341" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="12977" />
          <actual value="10335" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="14091" />
          <actual value="8631" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="14092" />
          <actual value="7852" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="22079" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="7512" />
          <actual value="5000" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="7512" />
          <actual value="5627" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="17032" />
          <actual value="12825" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="17032" />
          <actual value="14449" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="18236" />
          <actual value="11095" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="18236" />
          <actual value="8813" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="137404" />
        <baseline year="2016" iso-date="2016-12-31" value="105821">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="105821">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="105821">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="105821">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="105821">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="31583">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="31583">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="31583">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="31583">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="31583">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="49780">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="49780">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="49780">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="49780">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="51684">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="51684">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="51684">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="51684">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="51684">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="85720">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="85720">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="85720">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="85720">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="85720">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="102542">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="102542">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="102542">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="102542">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="102542">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="23921">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="23921">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="23921">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="23921">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="23921">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="10941">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="10941">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="10941">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="10941">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="10941">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="79312" />
          <actual value="64069" />
          <actual value="10267">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="25937">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="40386">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="53780">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="5099">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="49518">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="23683">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="79312" />
          <actual value="69840" />
          <actual value="54078">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="15762">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="25895">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="26094">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="43746">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="58712">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="6010">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="5142">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="71898" />
          <actual value="63527" />
          <actual value="54303">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="9224">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="27670">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="23302">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="40225">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="53804">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="4779">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="4944">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="71899" />
          <actual value="67812" />
          <actual value="53945">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="13867">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="26290">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="25114">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="42698">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="59816">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="3309">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="4687">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="74802" />
          <actual value="55794" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="74802" />
          <actual value="45169" />
          <actual value="39516">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="5653">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="20336">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="16475">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="28694">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="39945">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="1338">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="3837">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="94.58">
          <comment>
            <narrative>Numerator: 419; Denominator: 443.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="94">
            <comment>
              <narrative>Numerator: 423; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="96.4">
            <comment>
              <narrative>Numerator: 426; Denominator: 442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 423; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="96.2">
            <comment>
              <narrative>Numerator: 409; Denominator: 425.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="96">
            <comment>
              <narrative>Numerator: 432; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="97.5">
            <comment>
              <narrative>Numerator: 431; Denominator: 442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 432; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="97.3">
            <comment>
              <narrative>Numerator: 428; Denominator: 440.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="96">
            <comment>
              <narrative>Numerator: 432; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="97">
            <comment>
              <narrative>Numerator: 414; Denominator: 427.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 432; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="97.2">
            <comment>
              <narrative>Numerator: 388; Denominator: 399.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="100">
          <comment>
            <narrative>Numerator: 353; Denominator: 353.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 354; Denominator: 354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 327; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="99.7">
            <comment>
              <narrative>Numerator: 352; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="99.7">
            <comment>
              <narrative>Numerator: 352; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 353; Denominator: 353.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 120428; Denominator: 138423; Percentage: 87%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 69455; Denominator: 77172; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 53949; Denominator: 62059.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 69455; Denominator: 77172; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 54392; Denominator: 62354; Percentage: 87.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 71380; Denominator: 79312; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 55290; Denominator: 63543; Percentage: 87%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 71380; Denominator: 79312; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 60974; Denominator: 69388; Percentage: 87.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 64708; Denominator: 71898; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 54851; Denominator: 62823; Percentage: 87.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 64708; Denominator: 71899; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 59291; Denominator: 67236; Percentage: 88.2%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="57.99">
          <comment>
            <narrative>Numerator: 6351; Denominator: 10952.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 4796; Denominator: 5996.</narrative>
            </comment>
          </target>
          <actual value="57.8">
            <comment>
              <narrative>Numerator: 2950; Denominator: 5099.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 9592; Denominator: 11992.</narrative>
            </comment>
          </target>
          <actual value="66.3">
            <comment>
              <narrative>Numerator: 7490; Denominator: 11300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 4620; Denominator: 5435.</narrative>
            </comment>
          </target>
          <actual value="62">
            <comment>
              <narrative>Numerator: 3063; Denominator: 4944.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 9240; Denominator: 10871.</narrative>
            </comment>
          </target>
          <actual value="74.8">
            <comment>
              <narrative>Numerator: 7312; Denominator: 9781.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 5089.5; Denominator: 5655.</narrative>
            </comment>
          </target>
          <actual value="65">
            <comment>
              <narrative>Numerator: 2875; Denominator: 4422.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 10179; Denominator: 11310.</narrative>
            </comment>
          </target>
          <actual value="73.9">
            <comment>
              <narrative>Numerator: 6112; Denominator: 8270.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="92.44">
          <comment>
            <narrative>Numerator: 50663; Denominator: 54807.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 66837; Denominator: 70355.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 81279; Denominator: 83915.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 69210; Denominator: 72853.</narrative>
            </comment>
          </target>
          <actual value="97">
            <comment>
              <narrative>Numerator: 80373; Denominator: 82885.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="98">
            <comment>
              <narrative>Numerator: 78165; Denominator: 79760.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 112205; Denominator: 114755.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 80686.34; Denominator: 82333.</narrative>
            </comment>
          </target>
          <actual value="98.3">
            <comment>
              <narrative>Numerator: 112370; Denominator: 114312.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 86929.92; Denominator: 87808.</narrative>
            </comment>
          </target>
          <actual value="97.7">
            <comment>
              <narrative>Numerator: 101686; Denominator: 104128.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 89088.12; Denominator: 89988.</narrative>
            </comment>
          </target>
          <actual value="94.9">
            <comment>
              <narrative>Numerator: 122403; Denominator: 129022.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="46.58">
          <comment>
            <narrative>Numerator: 327; Denominator: 702.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 2477; Denominator: 4955.</narrative>
            </comment>
          </target>
          <actual value="17.6">
            <comment>
              <narrative>Numerator: 1956; Denominator: 11109.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 4955; Denominator: 9910.</narrative>
            </comment>
          </target>
          <actual value="13">
            <comment>
              <narrative>Numerator: 3795; Denominator: 29267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 2683; Denominator: 5366.</narrative>
            </comment>
          </target>
          <actual value="20.6">
            <comment>
              <narrative>Numerator: 2644; Denominator: 12844.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 5366; Denominator: 10732.</narrative>
            </comment>
          </target>
          <actual value="24.1">
            <comment>
              <narrative>Numerator: 6319; Denominator: 26261.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3212; Denominator: 6424.</narrative>
            </comment>
          </target>
          <actual value="24.4">
            <comment>
              <narrative>Numerator: 3194; Denominator: 13102.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 6424; Denominator: 12848.</narrative>
            </comment>
          </target>
          <actual value="32.3">
            <comment>
              <narrative>Numerator: 8453; Denominator: 26154.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="80.93">
          <comment>
            <narrative>Numerator: 111207; Denominator: 137404.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 71380; Denominator: 79312.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 54617; Denominator: 64069.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 71380; Denominator: 79312.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 63849; Denominator: 69839.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 64708; Denominator: 71898.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 58748; Denominator: 63527.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 64708; Denominator: 71899.</narrative>
            </comment>
          </target>
          <actual value="95.1">
            <comment>
              <narrative>Numerator: 64503; Denominator: 67812.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 67321; Denominator: 74802.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 54065; Denominator: 55794.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 67321; Denominator: 74802.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 43782; Denominator: 45169.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-UNOPS-5</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis - Myanmar (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, United Nations Office for Project Services</narrative>
    </description>
    <description type="2">
      <narrative>Goal: End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035) 50% reduction of TB incidence compared with 2015 baseline by 2025. Objectives: Expand TB services as part of Universal Health Coverage and strengthen partnerships; Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations; Achieve a faster decline in TB burden through an accelerated multisectoral TB response.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-UNOPSP05" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="67.27">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="32.73">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.59">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="26.68">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="0.17">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="ea41b061-34f4-4f5f-b2d7-d7e7838c9c59" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.44">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="7c509e7f-bfe6-4cf3-851a-a0a5a94b7401" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Civil registration and vital statistics</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="2.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="afeceaba-4839-4dc1-b17d-02d01f956207" percentage="0.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="1.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="4078713e-8351-4887-be1a-1617bf48ccd5" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="86ab2998-11d1-439b-a3b8-c56ee091314c" percentage="0.79">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; Policy and planning for national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="a47ec95d-9737-4650-ba19-86db996b3cdd" percentage="0.49">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Remuneration &amp; deployment of existing/new staff (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="0fa82570-990a-4ca3-98f1-4952587f8be1" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="951569a8-a591-40fc-9492-c7eb2322279f" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="23a802a3-2312-4589-bbe9-62a7cf2c91d2" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="1.3">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="452ec704-0b92-43c1-9cac-6649d925fde1" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="2.63">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="9a89bb7c-0497-4574-b9d1-dd46b1823c81" percentage="0.85">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a942b1dc-c2da-4e86-9902-fadb25203fd2" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key Populations (MDR-TB) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="0c56da86-a109-475c-888b-db26ea3235a8" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="0a397ad2-92e1-4673-8764-a74d9c839161" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="26.58">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="75ab2142-781a-4a2a-b8e0-50e6a129924b" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="22.46">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="9afa836c-5fc6-4ff5-973e-19cb5f9bc599" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="5.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="3.96">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="70cce1e1-1248-426c-b949-2fe2feec2c0a" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="0.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="1.2">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.18">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="0.86">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.98">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="44258a15-355f-4a95-8f2c-662ecb266256" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0.17">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.6">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="31f7c6af-8b6f-4289-90f3-c6f20f232eb7" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">17671130.62</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">25083415.12</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">39590608.22</value>
    </budget>
    <capital-spend percentage="8.17" />
    <transaction ref="770a4fa7-2e35-466b-8901-f6022035fc79">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-09" />
      <value currency="USD" value-date="2021-01-09">45509632.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fa273170-4146-43a4-9d92-f91e0252c996">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-13" />
      <value currency="USD" value-date="2021-01-13">11365561.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c2d79c3c-30d8-4e1d-b4e6-db49142db7d1">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e0f0a215-f59d-40f3-936e-4d6fc7d37ce6">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">4455819.62</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9acfc009-7fbd-4609-915b-9fee611d88b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-07" />
      <value currency="USD" value-date="2021-10-07">7066183.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21afdff1-dd2f-4c03-9c20-102a01dc3c62">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">6815438.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bb9bed2-13cf-424b-8549-97aec49d88b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">3905542.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3cd1454a-e511-4c30-8f58-31acc5477d6a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">-11901088.38</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="740642b5-0c0f-4c4d-9f88-374b8e484588">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">27153897.30</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c7f0faa-81f1-492f-b5d3-dc87900145be">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-19" />
      <value currency="USD" value-date="2022-12-19">11714739.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29e11aa4-9146-4afe-81ce-b9f82872e6e8">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4c934347-bc0f-465f-9050-1c5cfc7efc4b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-28" />
      <value currency="USD" value-date="2023-03-28">6270265.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3cfb80cc-7ee2-494c-8217-b84f5e922fbd">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-03" />
      <value currency="USD" value-date="2023-07-03">26555777.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5110cbbf-4c1a-4d13-8cf5-ad138aaf6a0a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-03" />
      <value currency="USD" value-date="2023-07-03">-9168893.30</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1d36ea56-da88-4e4a-9ba4-39c43c1a3cb7">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-06" />
      <value currency="USD" value-date="2023-07-06">11537417.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a8fa6a27-c877-4ac9-b2c4-19a10d68aaf2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">50000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="62f7dddf-afb4-4c17-91e7-fa8b72ad1765">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-23" />
      <value currency="USD" value-date="2023-08-23">14958360.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b4fbf93c-fc72-44b2-9c41-b4582d734bba">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-23" />
      <value currency="USD" value-date="2023-08-23">-15018360.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ae4b6d64-4f4b-4353-b845-d3bbd1318602">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">3619055.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="78b35318-6338-4db8-8db5-b152f7b211df">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-29" />
      <value currency="USD" value-date="2024-01-29">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="efe35f7e-fced-4af7-ab89-09d9afdc2d66">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-26460.16</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="758586de-06a9-49f8-8494-6a9c5c1d7d0a">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">26460.16</value>
      <description>
        <narrative>Funds returned to the Global Fund from MMR-T-UNOPSP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2430aece-60c8-46d2-a7c2-d91810f71758">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-23" />
      <value currency="USD" value-date="2025-06-23">-11339305.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="702bc583-88ba-4e2d-a9a6-c40b97ce05e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-3689613.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7602a1b-4425-4609-8648-a14c7b490cda">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">3689613.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from MMR-T-UNOPSP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP05-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">17671130.59</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP05, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP05-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">13667618.68</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP05, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP05-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">34145367.79</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP05, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP05-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">2268524.17</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP05, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MMR/2020/TB_HIV/en/MMR-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - TB/HIV - Myanmar - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR677-MMR-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="3205" />
        <baseline year="2019" iso-date="2019-12-31" value="3169">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3169">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3169">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3169">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3169">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3169">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="36">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="36">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="36">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="36">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="36">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="36">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1045">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1045">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1045">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1045">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1045">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2160">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2160">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2160">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2160">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2160">
          <dimension name="Gender" value="Male" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="1920" />
          <actual value="453" />
          <actual value="453">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="0">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="170">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="283">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="3840" />
          <actual value="1432" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="1920" />
          <actual value="979" />
          <actual value="958">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="21">
            <dimension name="Age" value="&lt;15" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="2174" />
          <actual value="1421" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="4348" />
          <actual value="2690" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="2174" />
          <actual value="1269" />
          <actual value="1260">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="9">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="449">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="820">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="2519" />
          <actual value="1355" />
          <actual value="1348">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="7">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="438">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="917">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5038" />
          <actual value="2628" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="2519" />
          <actual value="1273" />
          <actual value="1250">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="23">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="438">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="835">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="2581" />
        <baseline year="2019" iso-date="2019-12-31" value="2546">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2546">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2546">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2546">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2546">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2546">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="35">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="35">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="35">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="35">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="35">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="35">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="890">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="890">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="890">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="890">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="890">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="890">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1691">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1691">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1691">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1691">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1691">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1691">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="190">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="190">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="190">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="190">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="190">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="557">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="557">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="557">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="557">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="557">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="557">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="1728" />
          <actual value="528" />
          <actual value="526">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="2">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="212">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="316">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="178">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
          <actual value="100">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="3456" />
          <actual value="1295" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="1728" />
          <actual value="767" />
          <actual value="766">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="1">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="272">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="495">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="86">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="2000.08" />
          <actual value="1157" />
          <actual value="437">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="720">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="23">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
          <actual value="204">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="4000.2" />
          <actual value="2310" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="2000.08" />
          <actual value="1153" />
          <actual value="1144">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="9">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="395">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="758">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="34">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
          <actual value="330">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="2393.05" />
          <actual value="1289" />
          <actual value="1275">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="14">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="433">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="856">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="58">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
          <actual value="522">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="4786.2" />
          <actual value="2525" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="2393.05" />
          <actual value="1236" />
          <actual value="1223">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="13">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="424">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="812">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="198">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
          <actual value="525">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="48.98">
          <comment>
            <narrative>Numerator: 65190; Denominator: 133095.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 57910; Denominator: 72387.</narrative>
            </comment>
          </target>
          <actual value="32">
            <comment>
              <narrative>Numerator: 10390; Denominator: 32467.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 115820; Denominator: 144774.</narrative>
            </comment>
          </target>
          <actual value="32.4">
            <comment>
              <narrative>Numerator: 21200; Denominator: 65446.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 57910; Denominator: 72387.</narrative>
            </comment>
          </target>
          <actual value="32.8">
            <comment>
              <narrative>Numerator: 10810; Denominator: 32979.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 120146; Denominator: 141294.</narrative>
            </comment>
          </target>
          <actual value="39.4">
            <comment>
              <narrative>Numerator: 42462; Denominator: 107779.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="85.03">
            <comment>
              <narrative>Numerator: 60073; Denominator: 70647.</narrative>
            </comment>
          </target>
          <actual value="41.4">
            <comment>
              <narrative>Numerator: 19303; Denominator: 46612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="85.03">
            <comment>
              <narrative>Numerator: 60073; Denominator: 70647.</narrative>
            </comment>
          </target>
          <actual value="37.9">
            <comment>
              <narrative>Numerator: 23159; Denominator: 61167.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 61961; Denominator: 68846.</narrative>
            </comment>
          </target>
          <actual value="43">
            <comment>
              <narrative>Numerator: 26738; Denominator: 62155.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 123922; Denominator: 137692.</narrative>
            </comment>
          </target>
          <actual value="48">
            <comment>
              <narrative>Numerator: 61096; Denominator: 127184.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 61961; Denominator: 68846.</narrative>
            </comment>
          </target>
          <actual value="52.8">
            <comment>
              <narrative>Numerator: 34358; Denominator: 65029.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="2.6">
          <comment>
            <narrative>Numerator: 64; Denominator: 2460.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="2.51">
            <comment>
              <narrative>Numerator: 45; Denominator: 1792.</narrative>
            </comment>
          </target>
          <actual value="1.5">
            <comment>
              <narrative>Numerator: 11; Denominator: 713.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="2.5">
            <comment>
              <narrative>Numerator: 90; Denominator: 3584.</narrative>
            </comment>
          </target>
          <actual value="2.2">
            <comment>
              <narrative>Numerator: 25; Denominator: 1162.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="2.51">
            <comment>
              <narrative>Numerator: 45; Denominator: 1792.</narrative>
            </comment>
          </target>
          <actual value="3.1">
            <comment>
              <narrative>Numerator: 14; Denominator: 449.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="2.4">
            <comment>
              <narrative>Numerator: 92; Denominator: 3852.</narrative>
            </comment>
          </target>
          <actual value="4.1">
            <comment>
              <narrative>Numerator: 55; Denominator: 1341.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="2.39">
            <comment>
              <narrative>Numerator: 46; Denominator: 1926.</narrative>
            </comment>
          </target>
          <actual value="1.9">
            <comment>
              <narrative>Numerator: 9; Denominator: 475.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="2.39">
            <comment>
              <narrative>Numerator: 46; Denominator: 1926.</narrative>
            </comment>
          </target>
          <actual value="5.3">
            <comment>
              <narrative>Numerator: 46; Denominator: 866.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="2.27">
            <comment>
              <narrative>Numerator: 49; Denominator: 2160.</narrative>
            </comment>
          </target>
          <actual value="2.3">
            <comment>
              <narrative>Numerator: 27; Denominator: 1193.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="2.3">
            <comment>
              <narrative>Numerator: 98; Denominator: 4320.</narrative>
            </comment>
          </target>
          <actual value="2.8">
            <comment>
              <narrative>Numerator: 69; Denominator: 2437.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="2.27">
            <comment>
              <narrative>Numerator: 49; Denominator: 2160.</narrative>
            </comment>
          </target>
          <actual value="3.4">
            <comment>
              <narrative>Numerator: 42; Denominator: 1244.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="24671" />
        <baseline year="2019" iso-date="2019-12-31" value="2755">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2755">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2755">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2755">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2755">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="2755">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21916">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21916">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21916">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21916">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21916">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21916">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="27507" />
          <actual value="9163" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="13753" />
          <actual value="4038" />
          <actual value="319">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="3719">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="13754" />
          <actual value="5125" />
          <actual value="619">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="4506">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="27563" />
          <actual value="21267" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="13781" />
          <actual value="10833" />
          <actual value="904">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="9929">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="13782" />
          <actual value="10434" />
          <actual value="742">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="9692">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="13769" />
          <actual value="11567" />
          <actual value="658">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="10909">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="27538" />
          <actual value="25907" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="13769" />
          <actual value="14340" />
          <actual value="785">
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          </actual>
          <actual value="13555">
            <dimension name="Target / Risk population group" value="Others" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="1607" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="1230" />
          <actual value="27" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="2461" />
          <actual value="35" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="1231" />
          <actual value="8" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="3110" />
          <actual value="210" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="1555" />
          <actual value="76" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="1555" />
          <actual value="134" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="1514" />
          <actual value="243" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="3029" />
          <actual value="776" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="1515" />
          <actual value="533" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="20676" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="19979" />
          <actual value="11387" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="9989" />
          <actual value="4565" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9990" />
          <actual value="6822" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="10530" />
          <actual value="7631" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="21061" />
          <actual value="16968" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10531" />
          <actual value="9337" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="22581" />
          <actual value="18521" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="11290" />
          <actual value="9236" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11291" />
          <actual value="9285" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="27274" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="16287" />
          <actual value="14800" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="32574" />
          <actual value="27112" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="16287" />
          <actual value="12312" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="32510" />
          <actual value="37099" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="16255" />
          <actual value="17685" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="16255" />
          <actual value="19414" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="32357" />
          <actual value="39682" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="16178" />
          <actual value="19714" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="16179" />
          <actual value="19968" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="131425" />
        <baseline year="2019" iso-date="2019-12-31" value="108334">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="108334">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="108334">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="108334">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="108334">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="108334">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="23091">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="23091">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="23091">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="23091">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="23091">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="23091">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="53557">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="53557">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="53557">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="53557">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="53557">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="53557">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="48448">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="48448">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="48448">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="48448">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="48448">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="48448">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="82977">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="82977">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="82977">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="82977">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="82977">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="82977">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="117070">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="117070">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="117070">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="117070">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="117070">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="117070">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="6132">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="6132">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="6132">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="6132">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="6132">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="6132">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="9893">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="9893">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="9893">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="9893">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="9893">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="9893">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="71446" />
          <actual value="32088" />
          <actual value="29191">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="2896">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="13144">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="11637">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="20451">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="26402">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="3489">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="1949">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="142893" />
          <actual value="65801" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="71447" />
          <actual value="33713" />
          <actual value="29820">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="3743">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="14508">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="12339">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="21374">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="27402">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="4388">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="1923">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="139510" />
          <actual value="107086" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="69755" />
          <actual value="46612" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="69755" />
          <actual value="60474" />
          <actual value="47698">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="12577">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="23076">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="23046">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="37428">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="50039">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="7366">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="3069">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="67951" />
          <actual value="61534" />
          <actual value="51491">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="10043">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="25038">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="23062">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="38472">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="51837">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="6260">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="3437">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="135902" />
          <actual value="125954" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="67951" />
          <actual value="64420" />
          <actual value="51695">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="12725">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="25759">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="24874">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="39546">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="56682">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="3824">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="3914">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="1218" />
        <baseline year="2019" iso-date="2019-12-31" value="1218">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1218">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1218">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1218">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1218">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1218">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="5100" />
          <actual value="59" />
          <actual value="46">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="10200" />
          <actual value="250" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5100" />
          <actual value="191" />
          <actual value="187">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="13072" />
          <actual value="2261" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="6536" />
          <actual value="661" />
          <actual value="610">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="6536" />
          <actual value="1600" />
          <actual value="938">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="15970" />
          <actual value="5506" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="7985" />
          <actual value="2250" />
          <actual value="1004">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="7985" />
          <actual value="3256" />
          <actual value="1308">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="75.49">
          <comment>
            <narrative>Numerator: 7373; Denominator: 9767.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 10384; Denominator: 12217.</narrative>
            </comment>
          </target>
          <actual value="54.8">
            <comment>
              <narrative>Numerator: 2121; Denominator: 3872.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 5192; Denominator: 6108.</narrative>
            </comment>
          </target>
          <actual value="52.4">
            <comment>
              <narrative>Numerator: 1021; Denominator: 1949.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="84.99">
            <comment>
              <narrative>Numerator: 5192; Denominator: 6109.</narrative>
            </comment>
          </target>
          <actual value="57.2">
            <comment>
              <narrative>Numerator: 1100; Denominator: 1923.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="87.99">
            <comment>
              <narrative>Numerator: 5248; Denominator: 5964.</narrative>
            </comment>
          </target>
          <actual value="60.2">
            <comment>
              <narrative>Numerator: 1660; Denominator: 2756.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 10496; Denominator: 11928.</narrative>
            </comment>
          </target>
          <actual value="62.5">
            <comment>
              <narrative>Numerator: 3638; Denominator: 5825.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="87.99">
            <comment>
              <narrative>Numerator: 5248; Denominator: 5964.</narrative>
            </comment>
          </target>
          <actual value="64.5">
            <comment>
              <narrative>Numerator: 1978; Denominator: 3069.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 10568; Denominator: 11742.</narrative>
            </comment>
          </target>
          <actual value="70.7">
            <comment>
              <narrative>Numerator: 5200; Denominator: 7351.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 5284; Denominator: 5871.</narrative>
            </comment>
          </target>
          <actual value="65.9">
            <comment>
              <narrative>Numerator: 2264; Denominator: 3437.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 5284; Denominator: 5871.</narrative>
            </comment>
          </target>
          <actual value="75">
            <comment>
              <narrative>Numerator: 2936; Denominator: 3914.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="95.45">
          <comment>
            <narrative>Numerator: 125446; Denominator: 131425.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="96">
            <comment>
              <narrative>Numerator: 68589; Denominator: 71446.</narrative>
            </comment>
          </target>
          <actual value="88.4">
            <comment>
              <narrative>Numerator: 28351; Denominator: 32088.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 137178; Denominator: 142893.</narrative>
            </comment>
          </target>
          <actual value="87.7">
            <comment>
              <narrative>Numerator: 57676; Denominator: 65801.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 68589; Denominator: 71447.</narrative>
            </comment>
          </target>
          <actual value="87">
            <comment>
              <narrative>Numerator: 29325; Denominator: 33713.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 133930; Denominator: 139510.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 93221; Denominator: 107086.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="96">
            <comment>
              <narrative>Numerator: 66965; Denominator: 69755.</narrative>
            </comment>
          </target>
          <actual value="84.5">
            <comment>
              <narrative>Numerator: 39409; Denominator: 46612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 66965; Denominator: 69755.</narrative>
            </comment>
          </target>
          <actual value="89">
            <comment>
              <narrative>Numerator: 53812; Denominator: 60474.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="97">
            <comment>
              <narrative>Numerator: 131825; Denominator: 135902.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 115870; Denominator: 125954.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="97">
            <comment>
              <narrative>Numerator: 65912; Denominator: 67951.</narrative>
            </comment>
          </target>
          <actual value="89.8">
            <comment>
              <narrative>Numerator: 55274; Denominator: 61534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="97">
            <comment>
              <narrative>Numerator: 65913; Denominator: 67951.</narrative>
            </comment>
          </target>
          <actual value="94.1">
            <comment>
              <narrative>Numerator: 60596; Denominator: 64420.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MMR-T-UNOPS-6</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Fight Against Tuberculosis - Myanmar (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Myanmar, Tuberculosis, United Nations Office for Project Services</narrative>
    </description>
    <description type="2">
      <narrative>Goal: End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035) 50% reduction of TB incidence compared with 2015 baseline by 2025. Objectives: Expand TB services as part of Universal Health Coverage and strengthen partnerships; Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations; Achieve a faster decline in TB burden through an accelerated multisectoral TB response; Expand TB services as part of Universal Health Coverage and strengthen partnerships; Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations; Achieve a faster decline in TB burden through an accelerated multisectoral TB response.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Office for Project Services</narrative>
    </participating-org>
    <other-identifier ref="MMR-T-UNOPSP06" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="MM" percentage="100">
      <narrative>Myanmar</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="68.46">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="31.54">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.13">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="25.42">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="5a6fc5ba-08a3-455c-887d-00867a865303" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="f9c0078b-d557-4047-b352-b4b2eba7e5b8" percentage="0.39">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="eacd0e9d-d48a-433b-8461-31679dc01dc1" percentage="0.12">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Public financial management (PFM) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="9047155e-4a95-4897-b0bd-857d3f703670" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Routine financial management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="1e7328c2-4fcd-47b0-8e3c-31a8a421d74c" percentage="1.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="69e672f0-6d26-46e7-8e97-fcb0b6526cb4" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.47">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="2.61">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="2.68">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="5.93">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="14.03">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="20.84">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.66">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="8.94">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="10.96">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.6">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="0.64">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="1.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="d98eb915-d64b-45bb-8bae-93a530d37d6e" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Community care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="1.93">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">16010223.43</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">19259063.92</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">25711897.66</value>
    </budget>
    <capital-spend percentage="8.07" />
    <transaction ref="4560405c-4dbf-4594-bfd8-1a6f705c2e96">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-15" />
      <value currency="USD" value-date="2024-01-15">30908983.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4c9309a-e38d-4ccc-9e90-63ff7409bc2e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-18" />
      <value currency="USD" value-date="2024-01-18">5879168.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83ce2019-be83-43ef-ae4c-781981d1bdbc">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-23" />
      <value currency="USD" value-date="2024-05-23">1694890.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f04d609d-0b49-4609-9171-45e305b740e7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-27" />
      <value currency="USD" value-date="2024-06-27">3814607.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ae0885e6-f7b6-46a4-b92a-a9f015a9eeea">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-25" />
      <value currency="USD" value-date="2024-07-25">1743000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d5482233-fb42-4d2a-91ab-e46de3c6f257">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-26" />
      <value currency="USD" value-date="2024-09-26">6514630.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d36da9a3-aa7a-4cc7-a7cb-ca725f16fc91">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">1002168.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aa6f4396-dbfb-4b0f-a9ba-03fe4feb9423">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-25" />
      <value currency="USD" value-date="2025-03-25">2437750.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31098ee4-840d-417b-afab-8ad29459a099">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">3689613.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d948f84-748f-41b5-a015-1382ad03d73c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">3689613.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b928b790-16a7-459e-9177-e844a9638ce0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-03" />
      <value currency="USD" value-date="2025-07-03">-7822770.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="29e8bf38-e40d-487e-8c94-b73bbe15a06a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-03" />
      <value currency="USD" value-date="2025-07-03">6750000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63dfe4a0-207e-4432-8f8b-e267f08cd331">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">2550000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf83e97a-64e6-4910-9ec9-acfa189459cd">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">-4200000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="edda94f0-6882-4eb6-a101-575b555e0e96">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">7847000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="568f5d2e-588f-4eaf-be8c-71ba28e132cc">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-07" />
      <value currency="USD" value-date="2025-10-07">7847000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="efe603f2-1564-4964-aa59-94be597d3f26">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-10" />
      <value currency="USD" value-date="2026-01-10">10572184.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1161460d-7144-40ee-a22b-ee6d8093f55e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">1835000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="892192aa-8d02-4a59-8fae-49df77acb874">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">4243000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="faa8b6cf-7ed6-422a-ba90-b0149119e7de">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-29" />
      <value currency="USD" value-date="2026-06-29">-4494184.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="59a4e426-7af0-47a8-8c4c-e0a2dde493f0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-29" />
      <value currency="USD" value-date="2026-06-29">12424000.00</value>
      <description>
        <narrative>Global Fund commitment to MMR-T-UNOPSP06.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e0d9104e-28f9-4873-9a7e-63cec80c59ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">2724000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5103757a-d0af-4d79-af8b-a526482d3056">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">7053000.00</value>
      <description>
        <narrative>Global Fund disbursement to MMR-T-UNOPSP06 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="MMR-T-UNOPSP06-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">16010223.41</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP06, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MMR-T-UNOPSP06-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">15057866.54</value>
      <description>
        <narrative>Expenditure reported by United Nations Office for Project Services for MMR-T-UNOPSP06, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Office for Project Services</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MMR/2023/TB_HIV/en/MMR-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Myanmar - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1437-MMR-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="86.02">
          <comment>
            <narrative>Numerator: 20444; Denominator: 23767.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 14560.2; Denominator: 16178.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 29120.4; Denominator: 32356.</narrative>
            </comment>
          </target>
          <actual value="87.38">
            <comment>
              <narrative>Numerator: 27771; Denominator: 31782.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 14560.2; Denominator: 16178.</narrative>
            </comment>
          </target>
          <actual value="87.46">
            <comment>
              <narrative>Numerator: 13879; Denominator: 15869.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 29494.8; Denominator: 32772.</narrative>
            </comment>
          </target>
          <actual value="88.89">
            <comment>
              <narrative>Numerator: 25074; Denominator: 28209.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 14747.4; Denominator: 16386.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 14747.4; Denominator: 16386.</narrative>
            </comment>
          </target>
          <actual value="89.34">
            <comment>
              <narrative>Numerator: 13377; Denominator: 14973.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 15933.6; Denominator: 17704.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 15933.6; Denominator: 17704.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2690.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2670; Denominator: 2690; Percentage: 99.26%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2670; Denominator: 2690; Percentage: 99.26%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20; Denominator: 2690; Percentage: 0.74%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20; Denominator: 2690; Percentage: 0.74%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 956; Denominator: 2690; Percentage: 35.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 956; Denominator: 2690; Percentage: 35.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1734; Denominator: 2690; Percentage: 64.46%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1734; Denominator: 2690; Percentage: 64.46%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4132.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2431.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2066.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2066.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1260.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2401; Denominator: 2431; Percentage: 98.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 30; Denominator: 2431; Percentage: 1.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 840; Denominator: 2431; Percentage: 34.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1591; Denominator: 2431; Percentage: 65.45%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2079.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4158.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2633.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2079.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1318.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2598.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 35.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 941.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1692.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with RR-TB/MDR-TB who did not start treatment and/or started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of people with RR-TB/MDR-TB who did not start treatment and/or started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="15.02">
          <comment>
            <narrative>Numerator: 404; Denominator: 2690.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="14.23">
            <comment>
              <narrative>Numerator: 294; Denominator: 2066.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="14.2">
            <comment>
              <narrative>Numerator: 588; Denominator: 4132.</narrative>
            </comment>
          </target>
          <actual value="12.38">
            <comment>
              <narrative>Numerator: 311; Denominator: 2512.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="14.23">
            <comment>
              <narrative>Numerator: 294; Denominator: 2066.</narrative>
            </comment>
          </target>
          <actual value="11.28">
            <comment>
              <narrative>Numerator: 132; Denominator: 1170.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="13.1">
            <comment>
              <narrative>Numerator: 546; Denominator: 4158.</narrative>
            </comment>
          </target>
          <actual value="9.46">
            <comment>
              <narrative>Numerator: 238; Denominator: 2516.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="13.13">
            <comment>
              <narrative>Numerator: 273; Denominator: 2079.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="13.13">
            <comment>
              <narrative>Numerator: 273; Denominator: 2079.</narrative>
            </comment>
          </target>
          <actual value="8.78">
            <comment>
              <narrative>Numerator: 111; Denominator: 1264.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="12.01">
            <comment>
              <narrative>Numerator: 250; Denominator: 2082.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="12.01">
            <comment>
              <narrative>Numerator: 250; Denominator: 2082.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2341; Denominator: 2690; Percentage: 87.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2321; Denominator: 2341; Percentage: 99.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2321; Denominator: 2341; Percentage: 99.15%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20; Denominator: 2341; Percentage: 0.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20; Denominator: 2341; Percentage: 0.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 841; Denominator: 2341; Percentage: 35.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 841; Denominator: 2341; Percentage: 35.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 1761; Denominator: 2341; Percentage: 75.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 1761; Denominator: 2341; Percentage: 75.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1500; Denominator: 2341; Percentage: 64.08%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1500; Denominator: 2341; Percentage: 64.08%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 580; Denominator: 2341; Percentage: 24.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 580; Denominator: 2341; Percentage: 24.78%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1818; Denominator: 2066; Percentage: 88%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3636; Denominator: 4132; Percentage: 88%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2432; Denominator: 2431; Percentage: 100.04%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1818; Denominator: 2066; Percentage: 88%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1191; Denominator: 1260; Percentage: 94.52%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2398; Denominator: 2432; Percentage: 98.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 34; Denominator: 2432; Percentage: 1.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 881; Denominator: 2432; Percentage: 36.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 590; Denominator: 2432; Percentage: 24.26%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1551; Denominator: 2432; Percentage: 63.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 1842; Denominator: 2432; Percentage: 75.74%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3700; Denominator: 4158; Percentage: 89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2474; Denominator: 2633; Percentage: 93.96%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1850; Denominator: 2079; Percentage: 88.99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1850; Denominator: 2079; Percentage: 88.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1240; Denominator: 1318; Percentage: 94.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2441; Denominator: 2598; Percentage: 93.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 33; Denominator: 35; Percentage: 94.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 895; Denominator: 941; Percentage: 95.11%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 531.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1579; Denominator: 1692; Percentage: 93.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 1943.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1874; Denominator: 2082; Percentage: 90.01%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1874; Denominator: 2082; Percentage: 90.01%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1487; Denominator: 1962; Percentage: 75.79%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 386.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 386.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1076; Denominator: 1345; Percentage: 80%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2152; Denominator: 2690; Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1739; Denominator: 2289; Percentage: 75.97%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1076; Denominator: 1345; Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 814; Denominator: 1103; Percentage: 73.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1739; Denominator: 1739; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2460; Denominator: 3000; Percentage: 82%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1910; Denominator: 2558; Percentage: 74.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1230; Denominator: 1500; Percentage: 82%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1230; Denominator: 1500; Percentage: 82%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 943; Denominator: 1271; Percentage: 74.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1910; Denominator: 1910; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1735; Denominator: 2066; Percentage: 83.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1735; Denominator: 2066; Percentage: 83.98%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="210" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="468" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="936" />
          <actual value="637" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="468" />
          <actual value="423" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="850" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1700" />
          <actual value="692" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="850" />
          <actual value="422" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="877" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="877" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 116139.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 93797; Denominator: 116139; Percentage: 80.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 93797; Denominator: 116139; Percentage: 80.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 22342; Denominator: 116139; Percentage: 19.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 22342; Denominator: 116139; Percentage: 19.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 46917; Denominator: 116139; Percentage: 40.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 46917; Denominator: 116139; Percentage: 40.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 43736; Denominator: 116139; Percentage: 37.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 43736; Denominator: 116139; Percentage: 37.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 72403; Denominator: 116139; Percentage: 62.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 72403; Denominator: 116139; Percentage: 62.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 95506; Denominator: 111167; Percentage: 85.91%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 95506; Denominator: 111167; Percentage: 85.91%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 6138; Denominator: 111167; Percentage: 5.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 6138; Denominator: 111167; Percentage: 5.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 9523; Denominator: 111167; Percentage: 8.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 9523; Denominator: 111167; Percentage: 8.57%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 66882.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 133764.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 111468.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 66882.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 56707.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 94380; Denominator: 111468; Percentage: 84.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 17088; Denominator: 111468; Percentage: 15.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 50548; Denominator: 111468; Percentage: 45.35%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 43026; Denominator: 111468; Percentage: 38.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 68442; Denominator: 111468; Percentage: 61.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 100055; Denominator: 111468; Percentage: 89.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 6641; Denominator: 111468; Percentage: 5.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 4772; Denominator: 111468; Percentage: 4.28%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 141632.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 108396.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 70816.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 70816.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 53446.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 94670.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 13726.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 52660.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 41695.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 66701.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 98803.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 6240.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 3353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 73067.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 73067.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 63186; Denominator: 116139; Percentage: 54.41%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 10203; Denominator: 31655; Percentage: 32.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 10203; Denominator: 31655; Percentage: 32.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 52983; Denominator: 84484; Percentage: 62.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 52983; Denominator: 84484; Percentage: 62.71%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 43473; Denominator: 66882; Percentage: 65%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 86946; Denominator: 133764; Percentage: 65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 66780; Denominator: 111468; Percentage: 59.91%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 43473; Denominator: 66882; Percentage: 65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33839; Denominator: 56707; Percentage: 59.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 15032; Denominator: 66780; Percentage: 22.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 51748; Denominator: 66780; Percentage: 77.49%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 99142; Denominator: 141632; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 74110; Denominator: 108396; Percentage: 68.37%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 49571; Denominator: 70816; Percentage: 70%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 49571; Denominator: 70816; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37794; Denominator: 53446; Percentage: 70.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 12515.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 61595.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 54800; Denominator: 73067; Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 54800; Denominator: 73067; Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="14.61">
          <comment>
            <narrative>Numerator: 16967; Denominator: 116139.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="16">
            <comment>
              <narrative>Numerator: 21402; Denominator: 133764.</narrative>
            </comment>
          </target>
          <actual value="13.84">
            <comment>
              <narrative>Numerator: 15427; Denominator: 111468.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="16">
            <comment>
              <narrative>Numerator: 10701; Denominator: 66882.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="16">
            <comment>
              <narrative>Numerator: 10701; Denominator: 66882.</narrative>
            </comment>
          </target>
          <actual value="16.64">
            <comment>
              <narrative>Numerator: 9437; Denominator: 56707.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="17">
            <comment>
              <narrative>Numerator: 24078; Denominator: 141632.</narrative>
            </comment>
          </target>
          <actual value="14.26">
            <comment>
              <narrative>Numerator: 15453; Denominator: 108396.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="17">
            <comment>
              <narrative>Numerator: 12039; Denominator: 70816.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="17">
            <comment>
              <narrative>Numerator: 12039; Denominator: 70816.</narrative>
            </comment>
          </target>
          <actual value="11.98">
            <comment>
              <narrative>Numerator: 6405; Denominator: 53446.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="18">
            <comment>
              <narrative>Numerator: 13152; Denominator: 73067.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="18">
            <comment>
              <narrative>Numerator: 13152; Denominator: 73067.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 37185; Denominator: 116139; Percentage: 32.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 12899; Denominator: 37185; Percentage: 34.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 12899; Denominator: 37185; Percentage: 34.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Private facility type" value="NGO" />
          <comment>
            <narrative>Numerator: 3830; Denominator: 37185; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Private facility type" value="NGO" />
          <comment>
            <narrative>Numerator: 3830; Denominator: 37185; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Private facility type" value="Private for-profit" />
          <comment>
            <narrative>Numerator: 33355; Denominator: 37185; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Private facility type" value="Private for-profit" />
          <comment>
            <narrative>Numerator: 33355; Denominator: 37185; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 16386; Denominator: 66882; Percentage: 24.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 32772; Denominator: 133764; Percentage: 24.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34184; Denominator: 111468; Percentage: 30.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 16386; Denominator: 66882; Percentage: 24.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17681; Denominator: 56707; Percentage: 31.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 12489; Denominator: 34581; Percentage: 36.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Private facility type" value="NGO" />
            <comment>
              <narrative>Numerator: 9475; Denominator: 34581; Percentage: 27.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Private facility type" value="Private for-profit" />
            <comment>
              <narrative>Numerator: 25106; Denominator: 34581; Percentage: 72.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17704; Denominator: 70816; Percentage: 25%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35408; Denominator: 141632; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28210; Denominator: 108396; Percentage: 26.02%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17704; Denominator: 70816; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10484; Denominator: 53446; Percentage: 19.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 13221.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Private facility type" value="NGO" />
            <comment>
              <narrative>Numerator: 1479.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Private facility type" value="Private for-profit" />
            <comment>
              <narrative>Numerator: 26731.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 18632; Denominator: 73067; Percentage: 25.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18632; Denominator: 73067; Percentage: 25.5%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 60939; Denominator: 69952; Percentage: 87.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 67827; Denominator: 97800; Percentage: 69.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 67827; Denominator: 97800; Percentage: 69.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 652.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 652.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 61155.59; Denominator: 67951; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 122311.2; Denominator: 135902; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 97309; Denominator: 109985; Percentage: 88.47%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 61155.59; Denominator: 67951; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50672; Denominator: 56985; Percentage: 88.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 37880; Denominator: 97309; Percentage: 38.93%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 92060; Denominator: 97309; Percentage: 94.61%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 120387.2; Denominator: 133764; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 97407; Denominator: 111318; Percentage: 87.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 60193.61; Denominator: 66882; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60193.61; Denominator: 66882; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50230; Denominator: 56626; Percentage: 88.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 38487.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 92159.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 63733.9; Denominator: 70816; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 63733.9; Denominator: 70816; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1630.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Denominator: 1630; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Denominator: 1630; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3HP" />
          <comment>
            <narrative>Numerator: 910; Denominator: 1630; Percentage: 55.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3HP" />
          <comment>
            <narrative>Numerator: 910; Denominator: 1630; Percentage: 55.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 0; Denominator: 1630; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 0; Denominator: 1630; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 720; Denominator: 1630; Percentage: 44.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 720; Denominator: 1630; Percentage: 44.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1630; Denominator: 1630; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1630; Denominator: 1630; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 551; Denominator: 1630; Percentage: 33.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 551; Denominator: 1630; Percentage: 33.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 1079; Denominator: 1630; Percentage: 66.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 1079; Denominator: 1630; Percentage: 66.2%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5827.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11654.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8876.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5827.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4605.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3613; Denominator: 8876; Percentage: 40.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3HP" />
            <comment>
              <narrative>Numerator: 7612; Denominator: 8876; Percentage: 85.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 2530; Denominator: 8876; Percentage: 28.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 1264; Denominator: 8876; Percentage: 14.24%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 2733; Denominator: 8876; Percentage: 30.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 1163; Denominator: 8876; Percentage: 13.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 7713; Denominator: 8876; Percentage: 86.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 11445.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 22890.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11445.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10057.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 11259.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3HP" />
            <comment>
              <narrative>Numerator: 16573.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 4315.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 1780.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 2779.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 1855.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 16498.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 18204.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18204.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="71.79">
          <comment>
            <narrative>Numerator: 4502; Denominator: 6271.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="95.52">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4223; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="95.52">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4223; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="3.44">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 152; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="3.44">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 152; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1.04">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 46; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1.04">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 46; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="29.04">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1284; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="29.04">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1284; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="70.96">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3137; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="70.96">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3137; Denominator: 4421.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 8126; Denominator: 10836.</narrative>
            </comment>
          </target>
          <actual value="74.16">
            <comment>
              <narrative>Numerator: 4925; Denominator: 6641.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="74.99">
            <comment>
              <narrative>Numerator: 4063; Denominator: 5418.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="74.99">
            <comment>
              <narrative>Numerator: 4063; Denominator: 5418.</narrative>
            </comment>
          </target>
          <actual value="75.88">
            <comment>
              <narrative>Numerator: 2353; Denominator: 3101.</narrative>
            </comment>
          </actual>
          <actual value="95.41">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4699; Denominator: 4925.</narrative>
            </comment>
          </actual>
          <actual value="3.45">
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 170; Denominator: 4925.</narrative>
            </comment>
          </actual>
          <actual value="1.14">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 56; Denominator: 4925.</narrative>
            </comment>
          </actual>
          <actual value="32.08">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1580; Denominator: 4925.</narrative>
            </comment>
          </actual>
          <actual value="67.92">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3345; Denominator: 4925.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="76.99">
            <comment>
              <narrative>Numerator: 4564; Denominator: 5928.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="77">
            <comment>
              <narrative>Numerator: 9128; Denominator: 11856.</narrative>
            </comment>
          </target>
          <actual value="84.31">
            <comment>
              <narrative>Numerator: 5261; Denominator: 6240.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="76.99">
            <comment>
              <narrative>Numerator: 4564; Denominator: 5928.</narrative>
            </comment>
          </target>
          <actual value="81.41">
            <comment>
              <narrative>Numerator: 2391; Denominator: 2937.</narrative>
            </comment>
          </actual>
          <actual value="84.6">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5076; Denominator: 6000.</narrative>
            </comment>
          </actual>
          <actual value="81.05">
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 124; Denominator: 153.</narrative>
            </comment>
          </actual>
          <actual value="70.11">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 61; Denominator: 87.</narrative>
            </comment>
          </actual>
          <actual value="85.05">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1672; Denominator: 1966.</narrative>
            </comment>
          </actual>
          <actual value="83.97">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3589; Denominator: 4274.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80.01">
            <comment>
              <narrative>Numerator: 4998; Denominator: 6247.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80.01">
            <comment>
              <narrative>Numerator: 4998; Denominator: 6247.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 104315; Denominator: 116139; Percentage: 89.82%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 85405; Denominator: 101644; Percentage: 84.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 85405; Denominator: 101644; Percentage: 84.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 8079; Denominator: 101644; Percentage: 7.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 8079; Denominator: 101644; Percentage: 7.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 8160; Denominator: 101644; Percentage: 8.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 8160; Denominator: 101644; Percentage: 8.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 38175; Denominator: 101644; Percentage: 37.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 38175; Denominator: 101644; Percentage: 37.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63469; Denominator: 101644; Percentage: 62.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63469; Denominator: 101644; Percentage: 62.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 95506; Denominator: 111167; Percentage: 85.91%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 95506; Denominator: 111167; Percentage: 85.91%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 6138; Denominator: 111167; Percentage: 5.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 6138; Denominator: 111167; Percentage: 5.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 9523; Denominator: 111167; Percentage: 8.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 9523; Denominator: 111167; Percentage: 8.57%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 120388; Denominator: 133764; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106696; Denominator: 111468; Percentage: 95.72%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 60194; Denominator: 66882; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60194; Denominator: 66882; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 54123; Denominator: 56707; Percentage: 95.44%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 91192; Denominator: 106696; Percentage: 85.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 8866; Denominator: 106696; Percentage: 8.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 6638; Denominator: 106696; Percentage: 6.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 41015; Denominator: 106696; Percentage: 38.44%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 65681; Denominator: 106696; Percentage: 61.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 100055; Denominator: 110406; Percentage: 90.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 6641; Denominator: 110406; Percentage: 6.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 3710; Denominator: 110406; Percentage: 3.36%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 65859; Denominator: 70816; Percentage: 93%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 131718; Denominator: 141632; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 105043; Denominator: 108396; Percentage: 96.91%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 65859; Denominator: 70816; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 51801; Denominator: 53446; Percentage: 96.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 92369.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 7532.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 5142.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 40315.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 64728.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 98803.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 6240.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 3353.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 69413; Denominator: 73067; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 69413; Denominator: 73067; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>